Merck & Co Inc (NYSE:MRK)

62.52
Delayed Data
As of Jul 20
 +0.01 / +0.02%
Today’s Change
52.83
Today|||52-Week Range
66.41
+11.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line11.9B4.5B3.9B2.4B
 
 
 
 
 
Depreciation6.7B6.4B5.4B4.6B
 
 
 
 
 
Total Other Cash Flow-10.0B2.6B5.1B7.0B
 
 
 
 
 
Funds From Operations6.0B12.7B13.0B11.5B
 
 
 
 
 
Funds From/For Other Operating Expenses-1.8B268.0M2.6B5.0B
 
 
 
 
 
Net Cash Flow - Operating Activities7.9B12.4B10.4B6.4B
 
 
 
 
 
 
InvestingIncrease In Investments-24.9B-16.7B-15.7B-10.7B
 
 
 
 
 
Decrease In Investments15.1B20.4B14.4B15.7B
 
 
 
 
 
Capital Expenditures-1.3B-1.3B-1.6B-1.9B
 
 
 
 
 
Fixed Asset Disposal15.1B316.0M0.000.00
 
 
 
Net Assets From Acquisitions -4.9B-7.7B-780.0M-396.0M
 
 
 
 
 
Other Investing - Uses-80.0M0.000.00--
 
 
Other Investing - Sources614.0M221.0M482.0M38.0M
 
 
 
 
 
Net Cash Flow Investing-374.0M-4.8B-3.2B2.7B
 
 
 
 
 
 
FinancingShort Term Borrowings-460.0M-1.5B0.00-26.0M
 
 
 
 
Long Term Borrowings3.1B7.9B1.1B0.00
 
 
 
 
Long Term Debt Reduction-6.6B-2.9B-2.4B-1.1B
 
 
 
 
 
Net Proceeds Stock Sale1.6B485.0M939.0M499.0M
 
 
 
 
 
Common Preferred Redeemed-7.7B-4.2B-3.4B-4.0B
 
 
 
 
 
Common Dividends-5.2B-5.1B-5.1B-5.2B
 
 
 
 
 
Cash Dividends Paid - Total-5.2B-5.1B-5.1B-5.2B
 
 
 
 
 
Other Sources - Financing208.0M56.0M----
 
 
 
Other Uses - Financing77.0M0.00118.0M195.0M
 
 
 
 
Net Cash Flow - Financing-15.1B-5.3B-9.0B-10.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-553.0M-1.3B-131.0M457.0M
 
 
 
 
 
 
Net Change In Cash-7.6B2.4B-1.9B-880.0M